Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
4164 results about "In patient" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
/in·pa·tient/ (in´pa-shent) a patient who comes to a hospital or other health care facility for diagnosis or treatment that requires an overnight stay. inpatient. n. A patient who is admitted to a hospital or clinic for treatment that requires at least one overnight stay.
Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator
Methods and systems for monitoring, diagnosing and / or treating psychological conditions and / or disorders in patients with the aid of computer-based virtual reality simulations. Pursuant to one preferred embodiment, a computer program product is used to control a computer. The program product includes a computer-readable medium, and a controlling mechanism that directs the computer to generate an output signal for controlling a video display device. The video display device is equipped to display representations of three-dimensional images, and the output signal represents a virtual reality simulation directed to diagnosis and / or treatment of a psychological condition and / or disorder.
Owner:HEALTH HERO NETWORK
Spinal stabilization systems
ActiveUS20050113927A1Preserving and simulating flexionPreserving and simulating and extensionInternal osteosythesisJoint implantsSpinal columnFacetectomy
Spinal stabilizing elements and spinal stabilization systems composed of spinal stabilizing elements in combination with disc prostheses or disc nucleus replacements are provided. The stabilizing elements and stabilization systems are designed to preserve the natural mobility of vertebral discs and facet joints in patients with facet joint disease or patients who has undergone a prior destabilizing procedure, such as a facetectomy. The stabilizing elements may be pivoting elements or dynamic elements.
Owner:ST CLOUD CAPITAL PARTNERS III SBIC LP
Methods and devices for obstructing and aspirating lung tissue segments
InactiveUS6527761B1Reduce the possibilityIncrease anchorageMedical devicesMedical applicatorsLung volumesObstructive Pulmonary Diseases
Methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions using and comprising minimally invasive instruments introduced through the mouth (endotracheally) to isolate a target lung tissue segment from other regions of the lung and reduce lung volume. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port. Or, providing the port with a valve which allows outflow of gas from the isolated lung tissue segment during expiration of the respiratory cycle but prevents inflow of air during inspiration. In addition, a number of other methods may be used. The obstructive device may remain as an implant, to maintain isolation and optionally allow subsequent aspiration, or the device maybe removed at any time.
Owner:PULMONX
Artificial Cornea and Method of Making Same
Owner:WL GORE & ASSOC INC
Automatic infusion system based on an adaptive patient model
ActiveUS20050171503A1Ensuring wound repairReduces intensive care and hospital mortality and morbidityMedical devicesPressure infusionPatient modelDisease
Present invention is a system of blood glucose monitoring and intensive insulin therapy in a ICU for strict maintenance of normoglycemia which reduces intensive care and hospital mortality and morbidity of critically ill adult patients. The findings of present study also reveal factors determining insulin doses needed to maintain normoglycemia as well as the impact of insulin dose versus blood glucose level on the observed outcome benefits have been established. The invention provides a control system that adapts the flow of the insulin infusion based on insulin requirement calculated by blood glucose levels and clinical parameters such as history of diabetes, Body Mass Index, blood glucose level on admission, reason of ICU admission, time in the ICU, type and severity of illness, caloric intake, obesity, drugs affecting insulin sensitivity). This automated insulin monitoring systems significantly reduces the workload and human resource management problems for intensive insulin therapy in patients in the ICU.
Owner:K U LEUVEN RES & DEV
Pulse oximeter with motion detection
InactiveUS6879850B2Accurate operationImproving pulse-oximetryOptical sensorsBlood characterising devicesIntensive carePulse oximetry
There is a need for a technique to compensate for, or eliminate, motion-induced artifacts in patient-attached critical care monitoring instruments. Consequently, the invention is directed to improving pulse-oximetry by incorporating additional signals to aid in the triggering of the pulse-oximeter or in analyzing the data received by the pulse oximeter. This includes detecting when the patient moves and analyzing the pulse-oximetry data in light of the detected movement.
Owner:OPTICAL SENSORS
Implantable medical device for treating cardiac mechanical dysfunction by electrical stimulation
InactiveUS6738667B2Increase contractilityEasy to relaxCatheterHeart stimulatorsCardiac cycleHeart chamber
An implantable stimulator and monitor measures a group of heart failure parameters indicative of the state of heart failure employing EGM signals, measures of blood pressure including absolute pressure P, developed pressure (DP=systolic P-diastolic P), and / or dP / dt, and measures of heart chamber volume (V) over one or more cardiac cycles. These parameters include: (1) relaxation or contraction time constant tau (.tau.); (2) mechanical restitution (MR), i.e., the mechanical response of a heart chamber to premature stimuli applied to the heart chamber; (3) recirculation fraction (RF), i.e., the rate of decay of PESP effects over a series of heart cycles; and (4) end systolic elastance (E.sub.ES), i.e., the ratios of end systolic blood pressure P to volume V. These heart failure parameters are determined periodically regardless of patient posture and activity level. The physician can determine whether a particular therapy is appropriate, prescribe the therapy for a period of time while again accumulating the stored patient data for a later review and assessment to determine whether the applied therapy is beneficial or not, thereby enabling periodic changes in therapy, if appropriate. Drug therapies and electrical stimulation therapies, including PESP stimulation, and pacing therapies including single chamber, dual chamber and multi-chamber (bi-atrial and / or bi-ventricular) pacing can be delivered. In patient's prone to malignant tachyarrhythmias, the assessment of heart failure state can be taken into account in setting parameters of detection or classification of tachyarrhythmias and the therapies that are delivered.
Owner:MEDTRONIC INC
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
A method of inhibiting the release of a proinflammatory cytokine in a cell is disclosed. The method comprises treating the cell with a cholinergic agonist. The method is useful in patients at risk for, or suffering from, a condition mediated by an inflammatory cytokine cascade, for example endotoxic shock. The cholinergic agonist treatment can be effected by stimulation of an efferent vagus nerve fiber, or the entire vagus nerve.
Owner:THE FEINSTEIN INST FOR MEDICAL RES
Non-invasive treatment of neurodegenerative diseases
ActiveUS20110152967A1Reduce neuroinflammationReduce inflammationElectrotherapyMagnetotherapy using coils/electromagnetsRetinoidPostoperative cognitive dysfunction
Methods and devices are disclosed for the non-invasive treatment of neurodegenerative diseases through delivery of energy to target nervous tissue, particularly the vagus nerve. The devices include a magnetic stimulator having coils with toroidal windings, which are in contact with an electrically conducting medium that is adapted to conform to the contour of a target body surface of a patient. The coils induce an electric current and / or an electric field within the patient, thereby stimulating nerve fibers within the patient. The stimulation brings about reduction of neuroinflammation in patients suffering from conditions comprising Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, postoperative cognitive dysfunction and postoperative delirium. Reduction in inflammation is effected by enhancing the anti-inflammatory competence of cytokines such as TGF-beta, wherein a retinoid or components of the retinoic acid signaling system provide an anti-inflammatory bias, by enhancing anti-inflammatory activity of a neurotrophic factor such as NGF, GDNF, BDNF, or MANF, and / or by inhibiting the activity of pro-inflammatory cytokines such as TNF-alpha.
Owner:ELECTROCORE
Visual imaging system for ultrasonic probe
InactiveUS6540679B2Optimize locationDiagnostic probe attachmentInfrasonic diagnosticsTherapeutic treatmentNon invasive
A non-invasive visual imaging system is provided, wherein the imaging system procures an image of a transducer position during diagnostic or therapeutic treatment. In addition, the system suitably provides for the transducer to capture patient information, such as acoustic, temperature, or ultrasonic images. For example, an ultrasonic image captured by the transducer can be correlated, fused or otherwise combined with the corresponding positional transducer image, such that the corresponding images represent not only the location of the transducer with respect to the patient, but also the ultrasonic image of the region of interest being scanned. Further, a system is provided wherein the information relating to the transducer position on a single patient may be used to capture similar imaging planes on the same patient, or with subsequent patients. Moreover, the imaging information can be effectively utilized as a training tool for medical practitioners.
Owner:GUIDED THERAPY SYSTEMS LLC
Prediction of prostate cancer progression by analysis of selected predictive parameters
InactiveUS6025128AImprove performanceMicrobiological testing/measurementBiological testingStatistical analysisFactor ii
A method for screening individuals at risk for prostate cancer progression is disclosed. The method is useful for evaluating cells from patients at risk for recurrence of prostate cancer following surgery for prostate cancer. Specifically, the method uses specific Markovian nuclear texture factors, alone or in combination with other biomarkers, to determine whether the cancer will progress or lose organ confinement. In addition, methods of predicting the development of fatal metastatic disease by statistical analysis of selected biomarkers is also disclosed. The invention also contemplates a method that uses a neural network to analyze and interpret cell morphology data. Utilizing Markovian factors and other biomarkers as parameters, the network is first trained with a sets of cell data from known progressors and known non-progressors. The trained network is then used to predict prostate cancer progression in patient samples.
Owner:CYTODIAGNOSTICS +3
Method to determine the degree and stability of blood glucose control in patients with diabetes mellitus via the creation and continuous update of new statistical indicators in blood glucose monitors or free standing computers
InactiveUS20070010950A1Increase contributionShorten the timeDiagnostic recording/measuringSensorsInstabilityGlucose control
Microvascular complications of diabetes mellitus are closely related to blood glucose levels and fluctuations. The Glycostator statistical package was created to allow patients and health care providers simple access to “glycemic indicators” which permit a “snapshot view” of the effectiveness of the patient's diabetes management program. Glycostator functions provide a simple way of enhancing the information already provided by home blood glucose monitoring devices. To this end, a set of new indices, including one called the Virtual A1c, are computed in a recursive fashion from blood glucose test results to provide a more meaningful day-to-day assessment of glycemic control. All indices can be made available at the meter user interface on request. The displayed indices allow patients to improve glycemic control by identifying problems with blood glucose control and lability that are less easily recognized in traditional blood glucose meter statistical packages. Virtual A1c emulates hemoglobin A1c continuously and provides better day-to-day assessment of long term glycemic control than does the traditional average blood glucose report. The method for computing each of these indices, including the Virtual A1c, allows for their implementation in commercial blood glucose monitors.
Owner:ROCHE DIABETES CARE INC
Patient-specific hemodynamics of the cardio vascular system
ActiveUS20100241404A1Minimize model instabilityMore benefitMedical simulationAnalogue computers for chemical processesInstabilityRetrograde Flow
A noninvasive patient-specific method is provided to aid in the analysis, diagnosis, prediction or treatment of hemodynamics of the cardiovascular system of a patient. Coronary blood flow and pressure can be predicted using a 3-D patient image-based model that is implicitly coupled with a model of at least a portion of the remaining cardiovascular system. The 3-D patient image-based model includes at least a portion of the thoracic aorta and epicardial coronaries of the patient. The shape of one or more velocity profiles at the interface of the models is enforced to control complex flow features of recirculating or retrograde flow thereby minimizing model instabilities and resulting in patient-specific predictions of coronary flow rate and pressure. The invention allows for patient-specific predictions of the effect of different or varying physiological states and hemodynamic benefits of coronary medical interventions, percutaneous coronary interventions and surgical therapies.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Methods of monitoring conditions by sequence analysis
ActiveUS20100151471A1Maximize correlationMicrobiological testing/measurementBiological testingSequence analysisAutoimmune disease
There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer. Provided herein are methods for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions. Identified biomarkers can be used to determine the disease state for a subject with an autoimmune disease or other condition.
Owner:ADAPTIVE BIOTECH
Antimicrobial Needle Coating For Extended Infusion
InactiveUS20070299409A1Convenient and smoothResisting reducing absorptionSurgeryMedical devicesCoated surfaceMedicine
The present invention relates to bioabsorbable polymeric coatings with antimicrobial agents that provide coated surfaces that resist protein absorption and infectious formation on coated surfaces of medical devices that are inserted or implanted in patients, and kits thereof with an antimicrobial disc.
Owner:ANGIOTECH BIOCOATINGS
Left atrial appendage occlusion device
ActiveUS20070083230A1Reduce riskPrevention of clot formation and clot migrationOcculdersSurgical veterinaryClot formationLeft atrial appendage occlusion
The present invention provides devices and methods for occluding the left atrial appendage. The device includes an easily deployed wire structure of shape memory material sized to be appropriate for use in a patient. The device may be manufactured in various sizes for use in various patients. The device has a sheet of material attached for eclipsing the opening of the left atrial appendage and means for secured attachment substantially within the left atrial appendage. The method includes deploying the device within the left atrial appendage, securely anchoring the device, and ensuring that a sheet of material eclipses the opening of the left atrial appendage. These features are incorporated into the improved devices and methods in order to more effectively aid in the prevention of clot formation and clot migration into or out of the left atrial appendage to greatly decrease the risk of stroke in patients with atrial fibrillation.
Owner:JAVOIS ALEX
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
InactiveUS20070254295A1Eliminate side effectsCompound screeningApoptosis detectionAbnormal tissue growthSide effect
Owner:SOC DES PROD NESTLE SA
Spinal stabilization systems
ActiveUS7862586B2Preserving and simulating flexion and extension and lateral bending and compression and rotationInternal osteosythesisJoint implantsDiseaseSpinal column
Owner:ST CLOUD CAPITAL PARTNERS III SBIC LP
Cerebral perfusion augmentation
Owner:ZOLL CIRCULATION
Barrier device for ostium of left atrial appendage
InactiveUS6949113B2Effective isolationPrevent escapeElectrocardiographyDilatorsBlood vessel occlusionThrombus
Owner:BOSTON SCI SCIMED INC
System for managing glucose levels in patients with diabetes or hyperglycemia
A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.
Owner:INDIANA UNIVERSITY HEALTH
Visual imaging system for ultrasonic probe
InactiveUS20070167709A1Optimize locationEasy to determineDiagnostic probe attachmentInfrasonic diagnosticsSonificationNon invasive
A non-invasive visual imaging system is provided, wherein the imaging system procures an image of a transducer position during diagnostic or therapeutic treatment. In addition, the system suitably provides for the transducer to capture patient information, such as acoustic, temperature, or ultrasonic images. For example, an ultrasonic image captured by the transducer can be correlated, fused or otherwise combined with the corresponding positional transducer image, such that the corresponding images represent not only the location of the transducer with respect to the patient, but also the ultrasonic image of the region of interest being scanned. Further, a system is provided wherein the information relating to the transducer position on a single patient may be used to capture similar imaging planes on the same patient, or with subsequent patients. Moreover, the imaging information can be effectively utilized as a training tool for medical practitioners.
Owner:GUIDED THERAPY SYSTEMS LLC
Temperature monitoring of congestive heart failure patients as an indicator of worsening condition
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
InactiveUS20050125044A1Inhibition releaseImplantable neurostimulatorsHeterocyclic compound active ingredientsEfferentEndotoxic shock
A method of inhibiting the release of a proinflammatory cytokine in a cell is disclosed. The method comprises treating the cell with a cholinergic agonist. The method is useful in patients at risk for, or suffering from, a condition mediated by an inflammatory cytokine cascade, for example endotoxic shock. The cholinergic agonist treatment can be effected by stimulation of an efferent vagus nerve fiber, or the entire vagus nerve.
Owner:THE FEINSTEIN INST FOR MEDICAL RES
Automatic infusion system based on an adaptive patient model
ActiveUS7491187B2Reduces intensive care and hospital mortality and morbiditySafely reachedJet injection syringesMedical devicesPatient modelDisease
Present invention is a system of blood glucose monitoring and intensive insulin therapy in a ICU for strict maintenance of normoglycemia which reduces intensive care and hospital mortality and morbidity of critically ill adult patients. The findings of present study also reveal factors determining insulin doses needed to maintain normoglycemia as well as the impact of insulin dose versus blood glucose level on the observed outcome benefits have been established. The invention provides a control system that adapts the flow of the insulin infusion based on insulin requirement calculated by blood glucose levels and clinical parameters such as history of diabetes, Body Mass Index, blood glucose level on admission, reason of ICU admission, time in the ICU, type and severity of illness, caloric intake, obesity, drugs affecting insulin sensitivity). This automated insulin monitoring systems significantly reduces the workload and human resource management problems for intensive insulin therapy in patients in the ICU.
Owner:K U LEUVEN RES & DEV
Patient-specific spinal implants and related systems and methods
InactiveUS8246680B2Easy to implantAdditive manufacturing apparatusInternal osteosythesisCustom made implantReplacement implant
Methods and systems for generating custom implants by programmatically analyzing a patient's image data to electronically obtain shapes and dimensions of relevant anatomical features of a target region of the patient; and fabricating a patient-specific replacement implant for the patient using the analyzed patient image data. Related patient-specific spinal implants are also described.
Owner:MIMEDX PROCESSING SERVICES LLC
Medical systems and methods
A fluid management system for use in a tissue resection procedure includes a controller. An inflow pump is operated by the controller and configured to provide fluid inflow through a flow path to a site in patient's body. An outflow pump is operated by the controller and configured to provide fluid outflow through a flow path from the site in patient's body. A motor driven resecting device may be provided for resecting tissue at the site. The controller is configured to actuate an inflow pump and an outflow pump in response to various signals and various algorithms are provided to provide malfunction warnings and assure safe operation.
Owner:BOSTON SCI SCIMED INC
Implantable wireless sensor
InactiveUS20050187482A1Improve stabilityAvoid stickingEndoradiosondesCatheterLine sensorEndovascular aneurysm repair
The progress of a endovascular aneurysm repair can be monitored by inserting a pressure transducer sensor using a catheter into the sac during endovascular aneurysm repair and then using a small, hand-held read out device to measure pressure easily, safely, inexpensively and accurately. In one aspect a sensor is introduced into the body by the steps of loading the sensor into a catheter, and deploying into the aneurysm sac. This invention also has other applications for measuring physical properties in patients or in other sites.
Owner:CARDIOMEMS
Monitoring health and disease status using clonotype profiles
ActiveUS20110207134A1High sensitivityOvercome deficienciesMicrobiological testing/measurementAutoimmune diseaseBiomarker (petroleum)
There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer, especially lymphoid neoplasms, such as lymphomas and leukemias. Provided herein are methods for using DNA sequencing to identify personalized, or patient-specific biomarkers in patients with lymphoid neoplasms, autoimmune disease and other conditions. Identified biomarkers can be used to determine and / or monitor the disease state for a subject with an associated lymphoid disorder or autoimmune disease or other condition. In particular, the invention provides a sensitive method for monitoring lymphoid neoplasms that undergo clonal evolutions without the need to development alternative assays for the evolved or mutated clones serving as patient-specific biomarkers.
Owner:ADAPTIVE BIOTECH
Intraoral appliances with sensing
ActiveUS20180000563A1Patient compliance is goodGood curative effectMobile data collection deviceOthrodonticsBiomedical engineeringIntraoral appliance
Detection of placement of dental aligners in patient mouth on teeth for indication of wearing compliance. Described herein are apparatuses and methods for detecting wearing, including compliance, and for reliably transferring data, by wired or wireless direct or indirect communication of electronic compliance information to a smartphone. Also described herein are dental appliances that can detect physiological parameters related to respiration and sleep. Also described herein are aligner cases that enable NFC communication with electronic compliance indicator (ECI) devices and Bluetooth communication with smartphones.
Owner:ALIGN TECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com